The cologne stroke experience:: Safety and outcome in 450 patients treated with intravenous thrombolysis

被引:46
作者
Sobesky, Jan
Frackowiak, Monika
Weber, Olivier Zaro
Hahn, Moritz
Moeller-Hartmann, Walter
Rudolf, Jobst
Neveling, Michael
Grond, Martin
Schmulling, Susanne
Jacobs, Andreas
Heiss, Wolf-Dieter
机构
[1] Univ Cologne, Dept Neurol, Max Planck Inst Neurol Res, D-50924 Cologne, Germany
[2] Univ Cologne, Dept Diagnost Radiol, Cologne, Germany
[3] Univ Cologne, Dept Med Stat, Cologne, Germany
关键词
intravenous thrombolysis; modified Rankin scale; functional independence; stroke;
D O I
10.1159/000103117
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Predictors of outcome and safety in intravenous thrombolysis within 3 h in clinical routine is a matter of ongoing debate. Available reports contain small patient numbers or summarize heterogeneous multicenter data. Methods: Four hundred and fifty patients received intravenous thrombolysis within 3 h after stroke. Pretreatment NIHSS score and detailed medical history were analyzed. Noncontrast CT was performed before thrombolysis, 24-36 h later and in case of clinical deterioration. Symptomatic intracranial hemorrhage (SICH; any bleeding with an NIHSS increase of >= 4 points) and clinical outcome (modified Rankin Scale, mRS) after 3 months were recorded. Logistic regression identified parameters predictive of independence (mRS 0 - 2) and SICH. Results: Median onset to admission, door to needle and onset to treatment time was 75, 50 and 135 min, respectively. Direct presentation by emergency service (64%) was the fastest way of referral. Median pretreatment NIHSS was 11 points. Independence (mRS 0-2) was reached by 53%. Mortality was 11% (7% intracerebral, 4% extracerebral complications). Logistic regression identified low NIHSS, low age and absent diabetes as predictors of independence. Overall hemorrhagic complications and SICH were found in 18 and 4% of the patients, respectively. Extracerebral bleeding complications and allergic reactions were found in 3 and 1%, respectively. Conclusion: This largest single center report presents a sample in the range of the 3 h rt-PA cohort of all randomized controlled trials. Outcome was comparable to randomized studies with a higher rate of independence and a lower rate of mortality and SICH. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:56 / 65
页数:10
相关论文
共 50 条
[41]   Outcome of intravenous thrombolysis in acute ischemic stroke patients with small vessel disease [J].
Aboulfotooh, Alshaimaa M. ;
Rizk, Haytham ;
El Serafy, Omar ;
Ahmed, Sandra M. ;
Soliman, Nourhan M. .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 246
[42]   Impact of intravenous thrombolysis on recanalization rates in patients with stroke treated with bridging therapy [J].
Mueller, L. ;
Pult, F. ;
Meisterernst, J. ;
Heldner, M. R. ;
Mono, M. -L. ;
Kurmann, R. ;
Buehlmann, M. ;
Fischer, U. ;
Mattle, H. P. ;
Arnold, M. ;
Mordasini, P. ;
Gralla, J. ;
Schroth, G. ;
El-Koussy, M. ;
Jung, S. .
EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (08) :1016-1021
[43]   Prognostic significance of age in patients with acute ischaemic stroke treated with intravenous thrombolysis [J].
Wnuk, Marcin ;
Drabik, Leszek ;
Derbisz, Justyna ;
Slowik, Agnieszka .
NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2022, 56 (01) :81-88
[44]   Long-term medication persistence in stroke patients treated with intravenous thrombolysis [J].
Budimkic, Maja Stefanovic ;
Pekmezovic, Tatjana ;
Beslac-Bumbasirevic, Ljiljana ;
Ercegovac, Marko ;
Berisavac, Ivana ;
Stanarcevic, Predrag ;
Padjen, Visnja ;
Jovanovic, Dejana R. .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 141 :19-22
[45]   Blood pressure excursions in acute ischemic stroke patients treated with intravenous thrombolysis [J].
Tsivgoulis, Georgios ;
Katsanos, Aristeidis H. ;
Mandava, Pitchaiah ;
Kohrmann, Martin ;
Soinne, Lauri ;
Barreto, Andrew D. ;
Sharma, Vijay K. ;
Mikulik, Robert ;
Muir, Keith W. ;
Rothlisberger, Travis ;
Grotta, James C. ;
Levi, Christopher R. ;
Molina, Carlos A. ;
Saqqur, Maher ;
Mavridis, Dimitris ;
Psaltopoulou, Theodora ;
Vosko, Milan R. ;
Fiebach, Jochen B. ;
Sandset, Else Charlotte ;
Kent, Thomas A. ;
Alexandrov, Anne W. ;
Schellinger, Peter D. ;
Alexandrov, Andrei, V .
JOURNAL OF HYPERTENSION, 2021, 39 (02) :266-272
[46]   Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis [J].
Wahlgren, N. ;
Thoren, M. ;
Hojeberg, B. ;
Kall, T. -B. ;
Laska, A. -C. ;
Sjostrand, C. ;
Hoijer, J. ;
Almqvist, H. ;
Holmin, S. ;
Lilja, A. ;
Fredriksson, L. ;
Lawrence, D. ;
Eriksson, U. ;
Ahmed, N. .
JOURNAL OF INTERNAL MEDICINE, 2017, 281 (03) :273-283
[47]   Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis [J].
Amalia, Lisda ;
Qonitah, Putri .
EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01)
[48]   Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset [J].
Diedler, Jennifer ;
Ahmed, Niaz ;
Sykora, Marek ;
Uyttenboogaart, Maarten ;
Overgaard, Karsten ;
Luijckx, Gert-Jan ;
Soinne, Lauri ;
Ford, Gary A. ;
Lees, Kennedy R. ;
Wahlgren, Nils ;
Ringleb, Peter .
STROKE, 2010, 41 (02) :288-294
[49]   Safety and Outcome of Thrombolysis in Mild Stroke: A Meta-Analysis [J].
Shi, Lei ;
Zhang, Min ;
Liu, Hengfang ;
Song, Bo ;
Song, Changdong ;
Song, Dandan ;
Xu, Yuming .
MEDICAL SCIENCE MONITOR, 2014, 20 :2117-2124
[50]   Safety and Efficacy of Intravenous Thrombolysis for Patients With CADASIL Presenting With Acute Ischemic Stroke [J].
Chen, Huanwen ;
Colasurdo, Marco ;
Khunte, Mihir ;
Malhotra, Ajay ;
Gandhi, Dheeraj .
STROKE, 2024, 55 (11) :e300-e301